Zeno Pharma, Llc announced it raised in an initial filing
PUBLIC · ZNTLDec 19, 2017
Round Type
Venture
San DiegoBiotechnologyHealthcareMedicalTherapeuticsPharmaceuticalresearch
Company Information
Company
Zentalis Pharmaceuticals
Location
10275 Science Center Dr
San Diego, California, United States
About
Zentalis® Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1+ platinum-resistant ovarian cancer (PROC). Azenosertib is being evaluated as a monotherapy and in combination across multiple tumor types in clinical trials and has broad franchise potential. In clinical trials, azenosertib has been well tolerated and has demonstrated anti-tumor activity as a single agent across multiple tumor types. The Company is also leveraging its extensive experience and capabilities to translate its science to advance research on additional areas of opportunity for azenosertib outside PROC.
Fundz sees it the moment Zentalis Pharmaceuticals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
San DiegoBiotechnologyHealthcareMedicalTherapeuticsPharmaceuticalresearch